The flu vaccination campaign for pediatric ages began on July 3 in the province of Holguín, where a single dose of 0.5 ml will be applied to children from two to five years, 11 months and 29 days, as well as the first 0 .25 ml to infants from six months to one year.
The results of the scientific "complicity" of two Holguín women have begun to cross provincial borders. The idea for the project arose in January 2020, when one of them was struck by the COVID-19 figures reported in China.
Cuba is producing an 18F-fluorodeoxyglucose (18F-FDG) molecule, a radiopharmaceutical that stands out for its effectiveness in detecting tumors and other diseases.
The Biotechnological and Pharmaceutical Industries Group (BioCubaFarma) signed a new cooperation agreement with Chinese joint venture Changheber for the introduction of innovative immunotherapy for the treatment of cancer in the Asian country, it announced via Twitter.